XTL BIOPHARMACEUTICALS LTD

For the period ended Dec 31, 2025. Filed Jun 30, 2026.

About this filing

The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.

FY2025 · Filed Jun 30, 2026

XTLB$1.55-9.4%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Code of Ethics

ITEM 16B. CODE OF ETHICS

We have adopted a Code of Conduct applicable to all directors and officers of our company, including our principal executive officer, principal financial officer, principal accounting officer or controller and other individuals performing similar functions. A copy of our Code of Conduct can be found on our website (http://www.xtlbio.com) and may also be obtained, without charge, upon a written request addressed to our investor relations department, XTL Biopharmaceuticals Ltd., 85 Medinat Hayehudim St.Herzliya 4676670, Israel.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.